title: Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
authors.affiliation: University Hospital Leuven, Leuven Cancer Institute, Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven, Belgium European Union. Electronic address: Ignace.vergote@uzleuven.be.
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
authors.affiliation: Kliniken Essen Mitte, Department of Gynecology & Gynecologic Oncology, Essen, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: du Bois
authors.affiliation: University Hospital Leuven, Leuven Cancer Institute, Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven, Belgium European Union.
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.affiliation: Kliniken Essen Mitte, Department of Gynecology & Gynecologic Oncology, Essen, Germany.
authors.forename: Florian
authors.initials: F
authors.lastname: Heitz
authors.affiliation: University Hospital Leuven, Leuven Cancer Institute, Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven, Belgium European Union.
authors.forename: Karin
authors.initials: K
authors.lastname: Leunen
authors.affiliation: Kliniken Essen Mitte, Department of Gynecology & Gynecologic Oncology, Essen, Germany.
authors.forename: Philipp
authors.initials: P
authors.lastname: Harter
mesh_terms: D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery